Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD9291 (Osimertinib) | Mutant-Selective EGFR Inhibitor | CAS 1421373 ...
AZD9291 binding mode and structure. A, Structural model showing the ...
AZD9291 inhibits EGFR downstream signaling pathways and induces ...
AZD9291 (Osimertinib): A Breakthrough in Targeted Therapy for EGFR ...
The third-generation EGFR inhibitor AZD9291 overcomes primary ...
Acquired resistance to mutant-selective EGFR inhibitor AZD9291 is ...
AZD9291 inhibits GBM tumorigenesis in vivo. a Mice bearing U87 ...
AZD9291 inhibits EGFR phosphorylation and downstream signaling in ...
AZD9291 treatment is effective in erlotinib-resistant cells and induces ...
High efficacy of third generation EGFR inhibitor AZD9291 in a ...
AZ7550, an Active Metabolite of AZD9291 (EGFR TKI), Inhibits the ...
New EGFR inhibitor AZD9291 shows promising activity in treatment ...
Acquired resistance to AZD9291 as first-line treatment is mediated by ...
Structural Basis of AZD9291 Selectivity for EGFR T790M | Journal of ...
AZD9291 inhibits tumor growth in xenograft models through degradation ...
Additional characteristics of AZD9291 in vitro. A, AZD9291 demonstrates ...
Mechanisms of Acquired Resistance to AZD9291 - Journal of Thoracic Oncology
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR ...
Harmine increases the apoptosis that is induced by AZD9291 in EGFR ...
(PDF) APPLE trial: Feasibility and activity of AZD9291 (osimertinib ...
Acquired EGFR C797S mediates resistance to AZD9291 in advanced non ...
AZD9291 suppresses proliferation and migration of nasopharyngeal ...
AZD9291 Intermediates Synthesis EGFR Inhibitor CAS 1075705-01-9 - China ...
The combination of AZD9291 with a MEK inhibitor effectively inhibits ...
AZD 9291 Supplier | CAS 1421373-65-0 | AZD9291 | Tocris Bioscience
Proof-of-concept clinical studies validating AZD9291 as a... | Download ...
Covalent Modifiers: Refinement of Covalent EGFR Inhibitor AZD9291 to ...
AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual ...
In vivo antitumor efficacy of AZD9291 in subcutaneous xenograft models ...
DYRK1A siRNA increases the apoptosis that is induced by AZD9291 in EGFR ...
The combination of AZD9291 and HQP8361 stabilizes Bim protein (A and ...
MAPK inhibition cannot restore AZD9291 sensitivity in HCC827/AZDR ...
AZD9291 binding mode and structure. | Download Scientific Diagram
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is ...
AZD9291 使PRC2 复合物失活以介导肿瘤生长抑制。,Acta Pharmacologica Sinica - X-MOL
Figure 1 from The APPLE Trial: Feasibility and Activity of AZD9291 ...
JNJ-61186372 in combination with AZD9291 was effective and durable in ...
Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the ...
EGFR (epidermal growth factor receptor) TKI (tyrosine kinase inhibitor ...
AZD-9291 - Mutant EGFR Inhibitor | APExBIO
DYRK1A inhibitor harmine sensitizes EGFR wild‐type NSCLC cells to ...
Osimertinib (AZD-9291) | Mutant-Selective EGFR Inhibitor | MedChemExpress
Full article: Theoretical validation of some third-generation epidermal ...
Osimertinib (AZD9291) is an Orally Active EGFR Inhibitor for Lung ...
AZD-9291 API – High-Quality EGFR Inhibitor Supplier
Self-optimisation of the final stage in the synthesis of EGFR kinase ...
Figure 2 from Azd9291, an Irreversible Egfr Tki, Overcomes T790m ...
奥希替尼（AZD9291）的药理作用和耐药性 - 知乎
Effect of high dose-AZD9291 treatment after acquisition of EGFR-TKI ...
Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ...
Osimertinib (AZD9291) increases radio-sensitivity in EGFR T790M non ...
AZD 9291, Osimertinib, Third-generation, oral, irreversible, selective ...
API SYNTHESIS INTERNATIONAL: AZD 9291, Osimertinib, Third-generation ...
Advanced lung adenocarcinoma (LUAD) patient with EGFR mutations ...
(PDF) Discovery of a potent and selective EGFR inhibitor (AZD9291) of ...
泰瑞沙/奧希替尼(AZD9291)的療效優於一代EGFR-TKI？ - HKUOC
DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes ...
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR ...
Hypoxia induces resistance to EGFR inhibitors in lung cancer cells via ...
Figure 1 from Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor ...
AZD9291-resistant PC9 cells exhibit persistent ERK activation. (A ...
Efficacy of SHR‐A1403 on AZD9291‐resistant HA1 xenografts... | Download ...
重磅：AZD9291有望一線治療EGFR突變的轉移性非小細胞肺癌患者 - 每日頭條
(PDF) Abstract A109: AZD9291: an irreversible, potent and selective ...
AZD9291中间体2 1421372-94-2现货报价-盖德化工网
Figure 6 from Osimertinib (AZD9291) increases radio-sensitivity in EGFR ...
AZD9291-resistant PC9 cells contain an HRAS mutation. (A) Summary of ...
Osimertinib (AZD9291) 是选择性 EGFR 抑制剂｜MedChemExpress (MCE)_VanR_insFQEA_Calu
PLAC8 expression is upregulated in AZD9291-resistant NSCLC cell lines ...
具有抗肿瘤活性的EGFR酪氨酸激酶抑制剂BF3‑AZD9291及其制备方法和应用与流程
AZD9291-resistant PC9 cells show increased SerpinB5 levels after ...
印度奥希替尼azd9291一线治疗EGFR晚期非小细胞肺癌效果怎么样
Osimertinib (AZD9291)—a science-driven, collaborative approach to rapid ...
购买AZD9291;AZD-9291;AZD 9291;1421373-65-0;EGFR抑制剂;AMQUAR抑制剂-AMQUAR-Life ...
